Gossamer Bio Inc (GOSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 37,732 | 46,074 | 32,109 | 111,973 | 183,467 |
| Marketable Securities | 99,200 | 248,444 | 264,316 | 143,705 | 141,815 |
| Receivables | 12,227 | 5,338 | 0 | N/A | N/A |
| TOTAL | $167,644 | $309,888 | $306,519 | $261,880 | $331,780 |
| Non-Current Assets | |||||
| PPE Net | 64 | 10 | 1,648 | 3,981 | 5,320 |
| Other Non-Current Assets | 4,541 | 5,394 | 3,749 | 6,589 | 6,557 |
| TOTAL | $4,605 | $5,404 | $5,397 | $10,570 | $11,877 |
| Total Assets | $172,249 | $315,292 | $311,916 | $272,450 | $343,657 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 11,613 | 11,613 | N/A |
| Accounts payable and accrued liabilities | 5,959 | 2,319 | 5,526 | 1,459 | 3,244 |
| Accrued Expenses | 37,489 | 25,641 | 34,459 | 36,158 | 36,615 |
| Other current liabilities | 19,987 | 17,050 | 0 | N/A | N/A |
| TOTAL | $63,435 | $45,010 | $51,598 | $49,230 | $39,859 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 814 | 11,988 | 29,079 |
| Other Non-Current Liabilities | 231,574 | 240,790 | 196,735 | 199,155 | 153,256 |
| TOTAL | $231,574 | $240,790 | $197,549 | $211,143 | $182,335 |
| Total Liabilities | $295,009 | $285,800 | $249,147 | $260,373 | $222,194 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 234,696 | 227,221 | 225,582 | 94,985 | 76,477 |
| Common Shares | 24 | 23 | 23 | 10 | 8 |
| Retained earnings | -1,438,938 | -1,268,568 | -1,212,040 | -1,032,223 | -811,534 |
| Other shareholders' equity | -5,149 | 1,189 | -350 | -574 | 45 |
| TOTAL | $-122,760 | $29,492 | $62,769 | $12,077 | $121,463 |
| Total Liabilities And Equity | $172,249 | $315,292 | $311,916 | $272,450 | $343,657 |